Li L, Ye Y, Galimard J-E, Labopin M, Wu D, Chen J, Kröger N, Passweg J, Salmenniemi U, Itäla-Remes M, Poiré X, Eder M, Maertens J, Burns D, Sengeloev H, Olesen G, Blaise D, Finke J, Gadisseur A, Bazarbachi A, Brissot E, Nagler A, Luo Y, Shi J, Mohty M, Huang H, Ciceri F, Claude Gorin Sr. N. <i>TET2</i> mutation does not impact the prognosis of adult acute myeloid leukemia patients receiving a hematopoietic stem cell transplantation in first remission: similar outcome following matched sibling and unrelated <i>versus</i&gt; haploidentical donor transplants in a multi-center retrospective analysis from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Haematologica 2025;110(12):3088-3093; https://doi.org/10.3324/haematol.2025.287326.